• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Time to Invest in Healthcare Funds, Says The Wall Street Journal

    Charlotte McLeod
    Nov. 16, 2012 04:07PM PST
    Life Science Investing News

    The Wall Street Journal reported on how to reap the benefits of investing in healthcare funds, commenting that the bulk of the uncertainty surrounding the sector has been removed by the presidential election’s affirmation of the Affordable Care Act.

    The Wall Street Journal reported on how to reap the benefits of investing in healthcare funds, commenting that the bulk of the uncertainty surrounding the sector has been removed by the presidential election’s affirmation of the Affordable Care Act.

    As quoted in the market news:

    Health-care mutual funds have gained 19.7% on average in the 12 months through Nov. 15, and are up 12.6% each year over the past three years, according to investment-research firm Morningstar. By comparison, the Standard & Poor’s 500-stock index has gained 10.1% in the 12 months through Nov. 15.

    Investors have plowed $4 billion into health and biotechnology funds, including exchange-traded funds, this year through the end of October, according to Lipper. That already is more than double the nearly $1.9 billion the funds took in last year.

    The sector should benefit as baby boomers age, says Emerson Bell, a fee-only financial adviser at Halvorson-Boyd & Bell in Dallas who oversees about $50 million in assets. Primary-care physicians will do well under the health-care act, though specialists may suffer a bit, he says. But plenty of entrepreneurs will figure out how to make money under the new rules, he says.

    Click here to read the full report from The Wall Street Journal.

    presidential electionlife science investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

    5 Biggest Pharmaceutical ETFs in 2025

    Medical devices on a desk.

    How to Invest in Medical Device Stocks and ETFs

    Latest News

    Seegnal Inc. Announces Extension of Maccabi Health Services Contract

    Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×